Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATTNYSEARCA:BRWNASDAQ:ORIT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/ABRWSaba Capital Income & Opportunities Fund$7.72+0.3%$7.50$6.86▼$8.04N/AN/A169,204 shs11,848 shsORITOritani Financial$18.60$18.60$14.07▼$19.50$839.85M0.69230,803 shs3,486 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%BRWSaba Capital Income & Opportunities Fund+0.65%+1.72%+1.72%-2.28%+5.34%ORITOritani Financial0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/ABRWSaba Capital Income & Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AORITOritani FinancialN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/ABRWSaba Capital Income & Opportunities Fund 0.00N/AN/AN/AORITOritani Financial 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/ABRWSaba Capital Income & Opportunities FundN/AN/AN/AN/AN/AN/AORITOritani Financial$160.51M5.23$1.14 per share16.32$11.74 per share1.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ABRWSaba Capital Income & Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/AORITOritani Financial$52.06M$1.1815.76∞N/A31.46%9.63%1.26%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/ABRWSaba Capital Income & Opportunities FundN/AN/AN/AN/AN/AORITOritani Financial$0.723.87%N/A61.02%N/ALatest ORIT, BRW, WWH, and ATT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025BRWSaba Capital Income & Opportunities Fundmonthly$0.085013.5%5/9/20255/9/20255/30/20254/2/2025BRWSaba Capital Income & Opportunities Fundmonthly$0.085013.1%4/9/20254/9/20254/30/20253/3/2025BRWSaba Capital Income & Opportunities Fundmonthly$0.085013%3/11/20253/11/20253/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATTAbattis BioceuticalsN/AN/AN/ABRWSaba Capital Income & Opportunities FundN/AN/AN/AORITOritani Financial0.811.181.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/ABRWSaba Capital Income & Opportunities FundN/AORITOritani Financial68.31%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/ABRWSaba Capital Income & Opportunities FundN/AORITOritani Financial10.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableBRWSaba Capital Income & Opportunities FundN/AN/AN/ANot OptionableORITOritani Financial19445.15 millionN/AOptionableORIT, BRW, WWH, and ATT HeadlinesRecent News About These CompaniesInside Ora: Brand-New Hackensack Mixed-Use Building Nearly Ready To Start LeasingJanuary 11, 2025 | msn.comHow Personal Insurance Planning Fits Into A Financial PlanDecember 4, 2023 | forbes.comAmeriprise Financial Inc AMPNovember 5, 2023 | morningstar.comOritani Financial Stock Hits New 52-Week High (ORIT)June 22, 2023 | thestreet.comOritani Financial Stock To Go Ex-dividend Tomorrow (ORIT)January 9, 2023 | thestreet.comFinancial Literacy DefinitionSeptember 14, 2022 | investopedia.comLakeland Bank Announces 2022 Officer PromotionsApril 13, 2022 | abladvisor.comORIT_old Historical DataMarch 28, 2022 | investing.comNewly-Listed Teaneck Home Has Been Recently UpdatedJanuary 18, 2022 | msn.comPeoples Security Bank & Trust Announces Hires for First Business Center in NJSeptember 28, 2021 | njbmagazine.comWho’s Hiring In And Around New City: This Week’s Newest Job OpeningsSeptember 15, 2021 | msn.comLatest Job Openings In And Around Pleasantville-Briarcliff ManorSeptember 15, 2021 | msn.comWhite Plains Area Job Openings: Browse The LatestAugust 25, 2021 | msn.comNew Job Listings In And Around ScarsdaleAugust 25, 2021 | msn.comPort Chester Area Job Openings: Check Out The LatestAugust 11, 2021 | msn.comScarsdale Area Job Openings: Browse The LatestAugust 11, 2021 | msn.comLooking to capitalize on industrial growth, North Jersey's largest bank enters Philadelphia marketJuly 29, 2021 | bizjournals.comClifton resident named to head Kearny Bank Rutherford branchJuly 22, 2021 | publicnow.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsRetail Investors Are Betting Big on Rocket Lab—Should You Too?By Ryan Hasson | May 16, 2025View Retail Investors Are Betting Big on Rocket Lab—Should You Too?Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?By Nathan Reiff | May 10, 2025View Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockBy Chris Markoch | May 24, 2025View Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockORIT, BRW, WWH, and ATT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.Saba Capital Income & Opportunities Fund NYSEARCA:BRW$7.72 +0.02 (+0.26%) As of 10:50 AM EasternSaba Capital Income & Opportunities Fund is a closed-ended fixed income mutual fund launched by Voya Investment Management LLC. The fund is managed by Saba Capital Management, L.P. It invests in the fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in floating rate secured senior loans, with an emphasis on top-tier, non-investment grade senior loans. The fund seeks to invest in loans with maturities of one to ten years. It benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. The fund was formerly known as Voya Prime Rate Trust. Saba Capital Income & Opportunities Fund was formed on December 2, 1987 and is domiciled in the United States.Oritani Financial NASDAQ:ORITOritani Financial Corp. operates as a savings and loan holding company for Oritani Bank that provides various banking services for individual and corporate customers. The company accepts a range of deposit products, such as non-interest and interest-bearing demand and NOW checking accounts, money market deposit accounts, savings accounts, retirement accounts, and time deposits. Its loan products include residential commercial real estate loans comprising mortgage loans secured by apartment buildings; commercial real estate loans, consisting of mortgage loans secured by retail anchor shopping centers, commercial offices, retail space, warehouses, and mixed-use buildings; residential real estate loans, such as one to four family residential real property and home equity loans; and second mortgage and equity loans, and home equity lines of credit, as well as construction loans. The company also invests in securities and real estate properties. As of June 30, 2018, it operated 25 full service branches in Bergen, Hudson, Essex, and Passaic counties, New Jersey; and lending offices in New York City and Cherry Hill, New Jersey. Oritani Financial Corp. was founded in 1911 and is headquartered in Washington Township, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Steel Dynamics Shares Climb After Tariff Announcement Why Super Micro Computer's Upside Could Trigger a Short Squeeze Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Chewy Stock Gets a New $7.1 Billion Investor and Analyst Upgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
